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Abstract-The model assumes that following treatment there are two groups of patients, 
those with P proportion in the “cured” group and (1-P) in the “non-c*lred” group. Each 
group has a constant force of survival of each time interval, S for the first group 
and S 
.a 
for the second group. For most cancer, their surviva ll experience will be 
descrl ed by the cumulative proportion surviving to the ith year as 
si 
= Psi + (l-P)Si 
HOWeVer, for the breast cancer or those with similar curve, the survival experience 
will be described by a theoretical distribution give2n as 
SBi 
- Csi (l-e-Si) 
The normalizing factor is C = (1 + e 
-1)-l 
and Si is the first equation show”. The 
degree of spread of the cancer is the most important determinant of the nature and 
results of treatment. The stages of the disease can usually be defined, based on the 
size of the tumor, its extent of invasion of the organ, spread to surrounding organs, 
and the presence or absence of metastases. We should expect the parameters P, Sl and 
S2 to change according to the stages of the disease. That is, the proportion of 
“cured” and the survival rate of the “non-cured” decrease, as we go from local to 
regional, and to distant stage. In addition, the survival rate of the “cured” group 
should remain the same throughout the different disease extents. The survival rates 
for breast cancer patients of localized, regional and distant stages, diagnosed from 
1950 to 1959 and from 1960 to 1973 were analyzed by a computer program. For 
colorectal cancers, four different time periods from 1940 to 1969 were analyzed. This 
data shows in general the average survival time and the proportion of “cured”, 
decrease from localized to regional and to distant stages, which does reflect the 
extent of the disease. This model makes it possible to describe the entire course of 
survival by means of a curve obeying definite regularities. The regularities inferred 
by an objective analysis of clinical data correctly reflects the actual effects of the 
clinical facts. 
Keywords; Survival analysis, proportion of “cured”, average survival time, 
colorectal, breast cancer. 
INTRODUCTION 2) Let N 
individuals ir! 
and N2 be the initial number of 
each of the two groups 9 
In the analysis of survival curves, often respectively. Let P be the proportion of group 1 
some parametric form of distribution such as an individuals in the initial total patient 
exponential, lognormal or Weibull is assumed. The population. 
method of maximum likelihood or least squares is 
used to estimate the parameters. Boag (1949) and 
N = Nl + N2 and P = Nl/N. 
Berkson and Gage (1952) were the first to use this 
method. 
3, 
Assume the first group has a constant 
On the other hand, 
force of survival s1 and the second group has a 
non-parametric estimates constant force of survival s 
for the survival function can be obtained by the 
s2’ 
2’ 
I” general s1 # 
actuarial method or by the product-limit method as 
described by Miller in Survival Analysis (1981). 4) Let Si be the proportion of the total 
original group surviving through the ith time 
TWO GROUPS SURVIVAL interval. 
The mathematical model assumes that following 
treatment there are two groups of patients, with P 
proportion in the “cured” group and (1-P) 
proportion in the “non-cured” group. Each group 
has a constant force of survival of each time 
interval, and that proportion is S1 for the first 
group and S2 for the second group. 
The development of the two groups’ survival 
model is as follows: 
1) In the initial group of patients there 
are two independent subgroups of individuals whose 
survival times are being followed. 
5) Time intervals between successive S 
values are equal. 
1 
The cumulative curve is represented by the 
series Sl, S2, ..Sk and the ith term for the entire 
group may be written in terms of the two 
individual groups as 
Si = Psi + (l-P)Si . (1) 
Instead of using the s _, which are not 
independent, from the cumulativdsurvival curve of 
the total group, the series s 1, s2,...sk which is 
the set of observed proportion of the total group 
surviving each year is used. Thus, of all the 
627 
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individuals alive at the beginning of the ith time 
interval, s. proportion of them are still alive at 
the end ol the interval. The non-cumulative 
proportion is 
_- 
si = “i/si_l. (2) 
That is, the non-cumulative proportion is the 
proportion of individuals surviving at the end of 
the ith period divided by those entering the 
period. 
BREAST CANCER SURVIVAL 
A mathematical model for the survival of 
breast cancer patients has been proposed by the 
author (1977). The survival experience for breast 
cancer patients or those sites with similar curve, 
will be described by a theoretical distribution 
given as 2 
SBi = cSi (l+e-Si) (3) 
Where S. is 
normalizinlg factor C = (l+e ) 
given by e_qyionis (;iv,;d,u,; 
that SB = 1 at time zero. 
0 
The non-cumulative proportion is 
sB = 
i 
SBil SB (4) 
i-l 
The non-cumulative survival for the ith time 
period is the proportion of individuals surviving 
at the end of the period to those entering the 
period. 
MATERIALS AND MJZTHOD 
The three parameters P, Sl and S2 are to be 
estimated by minimizing the weighted error sum of 
Sq”i?r-ZS k 
Q = c W: 
i=l 
(si -s)2 
where si is the observed proportion20f the total 
group surviving each year and W. equals the 
number of people entering the ith year alive. 
Whereas, s is equation (2) for most other cancers 
and equation (4) for breast cancer or those with 
similar curve. 
The estimates of P, S 
solutions of the following norma ll 
and S 
2 are the equations 
k 
f(B) =c w: (Si -s) g = 0 
i=l - 
where 8’ = (PJl, S2). 
Then expand f(g) in a Taylor’s series about an 
estimate of the parameters 
aft9 
f(B) = f(S) + (2 - eJ ae 
- I’=B 
The initial values of G& are obtained by 
examining the sum of squares surface Q. The 
initial values of B 
the smallest sum ??f 
is the grid point at which 
square is found. These 
initial values are improved upon in the successive 
iterations using the Taylor’s series expansion on 
each parameters P, Sl and S2. 
To speed up the iterations, the directional 
cosines of the tangents to the sum of squares 
surface Q at the 
computed. 
point (PO, SlO, S20) are 
Then amend the directional vector by halving it if 
Q (gj+l)>Q(2j) 
or doubling it if 
This process of halving and doubling terminates 
until a local minimum of Q is found at step j. 
This whole iterative process continues until 
one is satisfied that the minimum Q is found 
within some practical limit. 
It can be shown that the least squares 
estimate of _ @ is also the maximum likelihood 
estimate of S. 
CHI SQUARE 
The chi square value is as follows 
Where Ai = the observed number alive at the 
end of the ith interval. 
Ni = the number of individuals entering 
the ith interval. 
Di = the observed number dying during 
the ith interval, 
and the non-cumulative survival for the ith time 
interval is equation (2) for most cancer and 
equation (4) for breast cancer or those with 
similar curve. 
The estimates of the parameters P, Sl and S 
are further refined by minimizing the chi-square a 
ValUe. These minimizing parameters are found by 
an efficient grid search procedure starting from 
the final values computed by the Taylor’s series 
expansion. This procedure is continued until the 
minimum value of the sum of chi-squared is 
attained. 
APPROXIMATE CONFIDENCE LIMITS 
The ellipsoidal confidence region obtained on 
the assumption that the linearized form of the 
model is valid around ‘&, the final estimate of 2 
is given by the formula (Draper and Smith, 1981, 
pg 472). 
(g -e, z g (g - g) 5 ps2 F (P, k-p, ^ , ^1 ^  1-m) 
where z denotes a matrix of the form by 
and 
SL = Q(g) 
(k-p) 
In this model, p = 3 as the number of 
parameters estimated and k is the number 0: 
intervals. 
When the confidence region is in this form, 
the simultaneous confidence limits of contrasts 
may be found by the method described by Scheffe’ 
so that 
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Actuarial life tables for COlOreCtal and 
breast cancer patients were provided by the 
Biometry Branch of the National Cancer Institute. 
The data were given in localized, regional and 
distant stages of the disease. The years of 
diagnoses were from 1950 to 1959 and from 1960 to 
1973 for breast cancer. For colon and rectum 
cancers, four different time periods 1940 to 1949, 
1950 to 1959, 1960 to 1964 and 1965 to 1969 were 
analyzed. 
INTERPRETATION AND APPLICATION 
The present model yields three parameters for 
the survival of a group of cancer patients. It is 
assumed that there are two subgroups, each with a 
different constant survival rate S andS. If 
the higher of the two S’s is appro?imately’equal 
to that of the normal population, the 
corresponding subgroup may be considered patients 
who have been “cured” with a given proportion P of 
the total group. 
The average survival time of a group of 
in lvlduals with a constant force of survival, S = 
.-d’ 
is given by 
Average Life = J_ = -1. (11) 
- 1”s 
x 
The average survival time for the combined 
group is the weighted average of the individual 
groups. 
Average Life (combined) = P(4) I (1-P) (&). 
Al x2 
In order to display the result more effectively, a 
graphic call biplot was developed. In the biplot, 
the abscissa represents the constant survival rate 
for the high or “cured” group and the ordinate 
represents the constant survival rate for the low 
or “non-cured” group. The proportion P of people 
belonging to the “cured” group is indicated by the 
size of the circle. 
The degree of spread of the cancer is the 
most important determinant of the nature and 
results of treatment. The stages of the disease 
can usually be defined based on the size of the 
t”lllOr, its extent of invasion of the organ, spread 
to surrounding organs, and the presence or absence 
of metastases. We should expect the parameters P 
and S 
the ~sease.* 2 
and S to change according to the stages of 
That is, the proportion of “cured” 
and the survival rate of the “non-cured” decrease, 
as we go from local to regional, and to distant 
stage. In addition, the survival rate of the 
“cured” group should remain the same throughout 
the different disease extents. 
COLORECTAL CANCER 
The analysis of survival for rectal cancer in 
females is shown in figure 1. The proportion of 
“cured” (the size of the circle) decreases from 
localized to regional and to distant stages. The 
survival rate of the “non-cured” group (ordinates) 
does not decrease from local to regional; however, 
it does decrease from regional to distant. The 
survival rate of the “cured” group is the same for 
localized and regional stages but it decreases 
somewhat in the distant stages. 
The analysis of survival for cancer of the 
rectum in males is shown in figure 2. In the 
analysis the male rectal cancer is about the same 
as female rectal cancer. However, the localized 
“non-cured” g’roup doesn’t fare as well as the 
regional “non-cured” group. The location of the 
circle on the figure is lower for localized cases 
than for regional cases. 
Figure 1. Female Rectal Cancer 
Figure 2. Male Rectal Cancer 
In figure 3 under descending colon for 
females the proportion of “cured” decreases from 
local to regional to distant stages. That is the 
same observation as in rectal cancer cases with 
one exception; the group of patients being 
diagnosed in 1960-1964. The survival rate for the 
“non-cured” group is considerably less than those 
of the regional cases diagnosed during the same 
time period. 
In the analysis of the descending colon in 
males (figure 4), the “non-cured” group in the 
localized stage has a lower survival rate than the 
“non-cured” groups in the regional stage. This 
has not occurred in the female cases quite as 
severely as in the male cases. Therefore, the 
question which arises here is, why do we have such 
a low survival rate for the non-cured group with 
localized disease? 
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BREAST CANCER 
I” looking at the various survival curve 
closely, you will notice that there are two types 
of curves. Indeed, the curve for breast cancer 
patients (Or those sites with similar curves) 
survival time is different, but you will notice 
that it does have a shoulder. That is breast 
cancer survivals have a more shallow slope than 
most other cancers at the beginning of the study. 
What it means is that the mortality rate is much 
less in the first year of study for breast cancer 
than for most other cancers. 
Kinetics is the science concerned with the 
development and mechanism of natural processes. 
There is no reason to believe that the kinetics is 
different between breast cancer and other cancers. 
The differences in survival curves are purely 
mathematical. Thus the basic two groups survival 
model discussed so far should still be correct for 
breast cancer. HOWeVer, due to the shoulder, the 
distribution function (3) will be used to describe 
the breast cancer survival experience. 
Table I shows the localized, female breast 
cancer of all ages diagnosed in 1960 to 1973. On 
the left side of the table is the actual observed 
data and on the right side is the theoretical 
estimate of this model. 
Figures 5, 6, and 7 show the cases of 
localized, regional and distant female breast 
cancer for all ages diagnosed from 1960 to 1973. 
The original observed survival curves for these 
data are indicated by (+) in the figures. The 
smooth curve is the theoretical survival curve as 
fitted by the present method. The straight lines 
indicate the constant survival rates for each of 
the two subgroups in the original population. 
Table II shows the three parameters with 95X 
simultaneous confidence limits, estimated by the 
present model from data of breast cancer diagnosed 
from 1960 to 1973. Also given are the combined 
average life and the tumor doubling time for the 
rapid growth cancer (1977) of the low survival 
group for these three stages of cancer. 
.* r-z-,. 
DESCENDING 
.* -_ 
COLON 
.’ .,“.. 
rsrru . ,_ - ., ,” _ 
5-r 
Figure 3. Female Descending Colon Cancer 
., 
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DESCENDING :; .“:,- I 
CDLON 
.a11 
Figure 4. Male Descending Colon Cancer 
The present model shows that for colorectal 
cancer, people with localized disease do not do as 
well as those with regional disease. The 
underlying cause of this reversal might be due to 
treatment affect. That is, somehow people with 
localized disease were either over treated or 
under treated with respect to people who have the 
regional disease. Clinical experience of 
physicians do encounter this reversal. 
TABLE I - Localized Female Breast Cancer, 
All Ages, Dx 1960-1973 
Actual Theoretical 
Corrected Percent Number percent 
Observed Alive 
16555 100.00 
15484.0 
13777.5 
11770.5 
9890.0 
0275.6 
6881.5 
5643.0 
4543.0 
3610.0 
2786.5 
2079.0 
95.26 
90.05 
84.52 
78.96 
74.01 
69.65 
65.70 
61.90 
58.52 
55.23 
52.43 
15408.7 
13773.7 
11816.4 
9952.1 
8287.2 
6861.2 
5615.4 
4532.0 
3595.8 
2786.2 
2071.9 
94.79 
89.59 
84.42 
79.36 
74.49 
69.89 
65.61 
61.66 
58.06 
54.79 
51.83 
1455.0 49.28 1468.5 49.17 
910.5 46.71 913.7 46.11 
456.0 44.38 457.9 44.62 
150.5 42.40 150.7 42.68 
18.0 42.40 17.3 40.93 
Entering Alive 
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Figure 5. Localized Female Breast Cancer, 
of all ages, diagnosed 1960-1973 
Figure 6. Regional Female Breast Cancer, 
of all ages, diagnosed 1960-1973 
Figure 7. Distant Female Breast Cancer, 
of all ages, diagnosed 1960-1973 
A visual summary of the results is shown in 
figures 8 and 9. Figure 8 shows the three stages 
of the disease diagnosed from 1950 to 1959, with 
localized (N=7762), regional (N=7538) and distant 
(N=2100). The proportion of “cured” decrease from 
local (63%), to regional (35%) and to distant 
(22%). Also, the survival rate of the “non-cured” 
group P as noted on the ordinate, decreases from 
local (76%) to regional (66%) and to distant 
(29%). 
Figure 9 shows the three stages of the 
disease diagnosed from 1960 to 1973, with 
localized (~=16555), regional (N=13992) and 
distant (N=3243). The proportion of “cured” 1s 
for localized (31%), regional (31%) and distant 
(26%). The survival rate of the “non-cured” group 
decreases from local (86%), to regional (71%) and 
to distant (16%). 
The observed and the expected five-year 
survival for female breast cancer patients are 
shown as: 
STAGES 
Local 
Regional 
Distant 
DX 1950-59 DX 1960-73 
Actual Theory Actual Theory 
72.86% 73.01% 74.01% 74.49% 
46.08% 46.23% 50.15% 50.12% 
13.97% 14.87% 7.90% 8.28% 
There was only a percentage point change from 
73% to 74% in the observed five-year survival for 
localized breast cancer diagnosed from the 1950 to 
1960. The present model shows that the average 
survival time had actually increased from 14 years 
to 23 years for the localized stage. However, the 
proportion of cured had dropped from 63% of those 
diagnosed in 1950-69 to 31% that werr? diagnosed in 
1960-73. 
According to the National Cancer Institute 
report #5 on cancer patient survival, which 
provided the data, the percent treated by surgery 
only had dropped from 64.5% in the 1950-1959 to 
56% in the 1960-1973, those treated by surgery and 
radiation had increased from 20.5% in 1950-1959 to 
26% in 1960-1973. A total of 14% changes has 
occurred in treatments during those two decades. 
Based on the present method of estimating 
average survival time, the treatment changes 
during these two time periods, do indeed extend 
patient lives for breast cancer. However, it 
seems that those patients who have benefited from 
these treatment changes may be fewer than 
expected. 
CONCLUSION 
This mathematical model makes it possible to 
describe the entire course of the survival by 
means of a curve obeying definite regularites. 
This method offers the opportunity of estimating 
the values of the parameters of the trajectory of 
the survival curve. 
These data show that average survival time 
and the proportion of “cured” in general does 
reflect the extent of the disease. The 
regularities inferred by an objective analysis of 
clinical data correctly reflects the actual 
effects of the clinical facts. 
In conclusion, kinetic analysis of the 
survival of cancer patients may furnish a base for 
scientific investigation, and a quantitative 
method for the rapid and accurate evaluation of 
the efficiency of treatments. 
632 5th ICMM 
TABLE II - Female Breast Cancer, All Ages, 
Diagnosed 1960-1973 
stages Localized Regional Distant 
P 
S High 
s Low 
Average Life 
Td (rapid) 
.3080 .I508 A 
.9832 .0227 + 
.8556 + .0202 
22.8Years 
17.8 Months 
.3142 l .0301 
.9514 5 .0072 
.7066 5 .0095 
8.2aYears 
7.99 Months 
.2593 + .00495 
.7378 T .5034 
.1605 5 .0030 
1.26Years 
1.53 Months 
Figure 8. Three Stages of Female Breast Cancer 
of all ages, diagnosed 1950-1959 
Figure 9. Three Stages of Female Breast Cancer 
of all ages, diagnosed 1960-1973 
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